GKSL Share Price Target 2035

CAGR-based price projection for Gujarat Kidney And Super Speciality Limited (GKSL) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (32.2% CAGR)
Rs 2,404
2035 Target
Base Case (80.6% CAGR)
Rs 39,737
2035 Target
Bull Case (294.1% CAGR)
Rs 44,536,708
2035 Target

Current Market Snapshot

CMP: Rs 194.27
52W High: Rs 194.27
52W Low: Rs 106.31
1Y CAGR: 226.2%
3Y CAGR: 80.6%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 257 Rs 351 Rs 766
2028 Rs 340 Rs 634 Rs 3,017
2029 Rs 449 Rs 1,145 Rs 11,890
2030 Rs 594 Rs 2,067 Rs 46,856
2031 Rs 786 Rs 3,734 Rs 184,653
2032 Rs 1,039 Rs 6,744 Rs 727,692
2033 Rs 1,374 Rs 12,181 Rs 2,867,726
2034 Rs 1,817 Rs 22,001 Rs 11,301,286
2035 Rs 2,404 Rs 39,737 Rs 44,536,708

Other GKSL Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the GKSL share price target for 2035?

Based on historical growth analysis, the GKSL share price target for 2035 ranges from Rs 2,404 (conservative) to Rs 39,737 (base case) to Rs 44,536,708 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of GKSL?

The current market price of GKSL (Gujarat Kidney And Super Speciality Limited) is Rs 194.27. The 52-week high is Rs 194.27 and 52-week low is Rs 106.31.

Is GKSL a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for GKSL price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 32.2% CAGR), Base (80.6% CAGR), and Bull (optimistic at 294.1% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.